Duke CTSI and North Carolina State University have announced the winner of its 2019-2020 Duke-NC State Translational Research Grant. Projects receiving this award must demonstrate stakeholder engagement and high translational potential with a clear path for continued development to move into clinical practice, generate new clinical guidelines, or other applications via subsequent grant support, new company formation, licensing, not-for-profit partnering, an evidence base that changes practices, or other channels.
The awarded project is eligible for up to $50,000 in funding each, provided by Duke CTSI and NC State. The funding cycle runs for one year, from July 1, 2019 to June 30, 2020.
The awardee for the Duke-NC State Translational Research Grant (2019-2020 cycle) is:
Pre-clinical validation of a novel interventional approach for Amyotrophic Lateral Sclerosis (ALS)
Duke Principal Investigator: Shivanand Lad
NCSU Principal Investigator: MIchael S. Bereman